Imunon, Inc.
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving Imunon, Inc. now
Current reporting with the operating signal separated from the noise.
Imunon, Inc.: IMUNON Reports Strong Enrollment Momentum in Phase 3 OVATION 3 Trial of IMNN-001 in Advanced Ovarian Cancer
The story matters when it changes Imunon, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Imunon, Inc. (IMNN) Q4 2025 Earnings Call Transcript
Investors are testing whether Imunon, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Imunon, Inc. Earnings Call Highlights Progress and Challenges
Investors are testing whether Imunon, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Imunon, Inc.: IMUNON Announces Reverse Stock Split
Investors are testing whether Imunon, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Imunon, Inc. (IMNN) Q1 2025 Earnings Call Transcript
Investors are testing whether Imunon, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.IMUNON, Inc. Initiates First Site for Phase 3 OVATION 3 Study of IMNN-001 in Advanced Ovarian Cancer, Announces ASCO Presentation
The story matters when it changes Imunon, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.IMUNON, Inc. Announces Phase 3 Trial for IMNN-001 Following Positive Phase 2 Survival Results in Advanced Ovarian Cancer
The story matters when it changes Imunon, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Latest IMNN filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
Imunon, Inc., quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
SEARCH Q1 COVERAGE →Second quarter
No verified period-specific item in the current feed.
SEARCH Q2 COVERAGE →Third quarter
No verified period-specific item in the current feed.
SEARCH Q3 COVERAGE →